World Health Organization (WHO) · Technical Documents

Viral hepatitis B as a public health problem (Resolution)

World Health Organization
View original document

The full text is hosted by the publishing organisation. lawenc.com indexes the metadata and links to the official source.

Full text

WPR/RC35.Rl4 VIRAL HEPATITIS B AS A PUBLIC HEALTH PROBLEM The Regional Committee, Having considered the report of the Regional Director on h~patitis as a public health problem;l Concerned at the high prevalence of viral hepatitis B in many countries of the Region and the e£fects of its lorig-term sequelae; Recognizing that technology for the production of a vaccine effective in preventing the transmission of hepatitis B virus exists in some countries of the Region, as well as sensitive and rapid methods of diagnosis usable at all levels; Considering that the cost of both vaccine and reagents could be substantially reduced through the further development of production within the Region; Considering also the need to intensify research for the development of new vaccines and diagnostic reagents; 1. URGES Member States: ( 1) to formulate programmes for the prevention and control of viral hepatitis B and to init·iate these progratntDes in a phased manner; (2) to strengthen laboratory capability to ensure that aero-epidemiological s~~veys of the population are effectively carried out, particular attention being given to such groups as blood donors, pregnant women and persons at high risk of infection; 2. REQUESTS the Regional Director: (1) to stimulate the further development, production and monitoring of safe, effective and low-cost hepatitis B vaccine derived from human plasma and o£ diagnostic reagents; (2) to develop a vaccination scheme, covering the most vulnerable groups such as newborns and using the most appropriate dosage; (3) to encourage research on the development of a vaccine using modern biotechnology~ in particular technolo~y, with a view to its eventual production; new hepatitis B recombinant DNA (4) to continue to strengthen cooperation with Member States in the exchange of information an~ training of scientists; (5) to foster cooperation between countries in the transfer of technology for the production of vaccines and diagnostic reagents; (6) to continue in his endeavours to mobilize extrabudgetary resources and to increase the allocation of such resources to the progratmne for prevention and control of viral hepatitis B. Eighth meeting~ 11 September 1984 lnocument WPR/RC35/ll.

Key facts
Document type Technical Documents
Adoption date
Source World Health Organization